Millipore Completes Second New Viral Vector CDMO Facility
MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, opened its second Carlsbad, CA-based facility to serve gene and cell therapy clients. The new $110 million, 140,000 ft2 facility will...
Overcoming Plasmid DNA Limitations in Advanced Therapy Manufacturing
Broadcast Date: December 6, 2021Time: 8:00 am PT, 11:00 am ET, 1700 CET
REGISTER NOW
The genetic medicine revolution is truly underway. The COVID-19 pandemic has allowed mRNA and DNA-based vaccines to show their true...
Why We’re Launching GEN Biotechnology – Genetic Engineering & Biotechnology News
In 1981, Genetic Engineering and Biotechnology News launched as the newspaper of record for the fledgling biotechnology industry. Publications come and go, but GEN has stayed the course for the past 40 years, providing...
PDS Biotechnology Announces Conference Call and Webcast to – GlobeNewswire
FLORHAM PARK, N.J., Oct. 13, 2021 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage immunotherapy company developing novel cancer therapies based on the Company’s proprietary Versamune® T-cell activating technology, will release financial...
New Genome Center to Focus on Genetics of People of Admixed Ancestry
Researchers at the University of California (UC) San Diego School of Medicine have been awarded $11.7 million to launch the Genetic & Social Determinants of Health: Center for Admixture Science and Technology (CAST) to...
Fraunhofer researchers investigate how viruses can be efficiently eliminated from indoor air
How can viruses be effectively eliminated from indoor air? This question is now becoming more important as fall approaches. Efficient indoor air purification is essential, especially in schools. Fraunhofer researchers are investigating and optimizing...
Researchers uncover how cancer cells use sugar residue to evade the immune system
A team of South Dakota State University chemistry researchers uncovered how cancer cells utilize a simple sugar residue to disguise themselves from the immune system. What they learned will help scientists develop more effective...
From Junk to Treasure: Syros Pharmaceuticals Mines Non-Coding DNA to Treat Disease
Syros is advancing a robust clinical-stage pipeline that includes: tamibarotene, a first-in-class oral selective RARα agonist in RARA-positive patients with higher-risk myelodysplastic syndrome and acute myeloid leukemia (AML); SY-2101, a novel oral form of...
New compound can prevent SARS-CoV-2 and related coronaviruses from entering cells
Scientists at Washington University School of Medicine in St. Louis have developed a compound that prevents SARS-CoV-2 and related coronaviruses from entering cells. The researchers are collaborating with the National Institutes of Health (NIH)...
New algorithm provides a high-definition analysis of genome organization in single cells
Within the microscopic boundaries of a single human cell, the intricate folds and arrangements of protein and DNA bundles dictate a person's fate: which genes are expressed, which are suppressed, and -; importantly -;...
